Use the implementation process to reset, redefine and deliver on your goals.

The introduction of a new generic medication to prevent the spread of HIV improves affordability – but only if plan sponsors encourage use and adherence.

Gene modification and cellular therapies are unique, potentially curative treatments that leverage gene-altering technology

The promise and challenges of semaglutide, a new therapy for weight loss

- Patients enrolled in the Weight Management Care Value program from Express Scripts also benefit from robust personalized coaching, digital tracking tools and peer support
- MDLIVE physicians will be available to meet with WMCV participants virtually and can prescribe appropriate weight loss medications, including Wegovy, for eligible patients.
- Industry-leading value-based care model provides employers and health plans with greater affordability and predictability

These alternatives to biologics offer the opportunity for up to $375 billion in savings over the next 10 years

Evernorth Workplace Care delivers high-quality, dedicated health and wellness services at the worksite, virtually or through a hybrid model. Our proactive “care where you are” approach for managing population health provides greater access to convenient care while driving better outcomes and lowering costs.

Recent research suggests that the number of gene therapies on the market is likely to increase to over 60 by 2030. As rapid advancements in the field continue, here is what plan sponsors can expect to see in the shifting U.S. health care system.

Virtual health care and digital health care are often mentioned together, but their differences are notable. Today, they’re used in parallel more often than in tandem.